Gunasekera Anusha M, Wickramarachchi Thilan, Neafsey Daniel E, Ganguli Ishani, Perera Lakshman, Premaratne Prasad H, Hartl Daniel, Handunnetti Shiroma M, Udagama-Randeniya Preethi V, Wirth Dyann F
Department of Immunology and Infectious Diseases, Harvard School of Public Health, Harvard University, USA.
Mol Biol Evol. 2007 Apr;24(4):939-47. doi: 10.1093/molbev/msm013. Epub 2007 Jan 22.
Plasmodium vivax apical membrane antigen 1 (PvAMA-1) is an important malaria vaccine candidate. We present the first comprehensive analysis of nucleotide diversity across the entire PvAMA-1 gene using a single population sample from Sri Lanka. In contrast to what has been observed at the AMA-1 locus of Plasmodium falciparum, the signature of diversifying selection is seen most strongly in Domain II of PvAMA-1, indicating that the different domains in each species may be subject to varying selective pressures and functional constraints. We also find that recombination plays an important role in generating haplotype diversity at this locus, even in a region of low endemicity such as Sri Lanka. Mapping of diversity and recombination hotspots onto a 3-dimensional structural model of the protein indicates that one surface of the molecule may be particularly likely to bear epitopes for antibody recognition. Regions of this surface that show constrained variability may prove to be promising vaccine targets.
间日疟原虫顶端膜抗原1(PvAMA-1)是一种重要的疟疾疫苗候选物。我们使用来自斯里兰卡的单一种群样本,首次对整个PvAMA-1基因的核苷酸多样性进行了全面分析。与在恶性疟原虫AMA-1位点观察到的情况相反,多样化选择的特征在PvAMA-1的结构域II中最为明显,这表明每个物种中的不同结构域可能受到不同的选择压力和功能限制。我们还发现,重组在该位点产生单倍型多样性方面发挥着重要作用,即使在像斯里兰卡这样低流行地区也是如此。将多样性和重组热点映射到该蛋白质的三维结构模型上表明,该分子的一个表面可能特别容易携带抗体识别的表位。该表面显示出受限变异性的区域可能被证明是有前景的疫苗靶点。